CDK6 and non-small cell lung carcinoma: CDK6, which is a member of the family of cyclin-dependent kinases, has been identified as a tumor oncogene that was upregulated and in a series of adenocarcinomas, including such as in breast cancer and non-small cell lung cancer [32, 33].